CYCLO3PSS CORP
S-8, 1999-05-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: WITTER DEAN WORLD CURRENCY FUND L P, 10-Q, 1999-05-14
Next: TUFCO TECHNOLOGIES INC, 10-Q, 1999-05-14





===============================================================================

     As filed with the  Securities  and Exchange  Commission on May 13, 1999 

                              SEC File No. 0-22720
- ------------------------------------------------------------------------------
Registration No. 33-


                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549
                           ------------------------


                                   FORM S-8
                            REGISTRATION STATEMENT
                                     Under
                          The Securities Act of 1933
                           ------------------------


                              CYCLO3PSS CORPORATION
            (Exact name of Registrant as specified in its charter)

      Delaware                                                  87-0455642
     ----------                                                -------------
(State or other jurisdiction of                             (I.R.S. Employer
incorporation or organization)                             Identification No.)

                             3646 West 2100 South
                          Salt Lake City, Utah 84120
                   (Address of principal executive offices)
                           ------------------------

     Employment  Agreement of William R. Stoddard,  Employment  Agreement Durand
Smith,  Employee Stock Option  Agreements with William R. Stoddard,  Mondis Nkoy
and John M. Williams

         Grant of Shares to William R. Stoddard in Lieu of Cash Wages
         ------------------------------------------------------------
                             (Full title of plans)

                              William R. Stoddard
                             Cyclo3pss Corporation
                             3646 West 2100 South
                           Salt Lake City, UT 84120
                         ----------------------------
                    (Name and address of agent for service)

                                (801) 972-9090
                    (Telephone number of agent for service)
                           ------------------------

                                with copies to:

                            A.O. Headman, Jr., Esq.
                        Cohne, Rappaport & Segal, P.C.
                       525 East First South, Fifth Floor
                           Salt Lake City, UT 84102
                                (801) 532-2666


<TABLE>
<CAPTION>
                        CALCULATION OF REGISTRATION FEE

Title of Securities      Amount to be        Proposed Maximum           Proposed Maximum      Amount of
to be Registered         Registered(1)       Offering Price Per Unit    Aggregate Offering    Price Registration Fee
- ---------------------------------------------------------------------------------------------------------------------
<S>                      <C>                      <C>                   <C>                   <C>

Common Stock             815,000(2)               $  .10                $ 81,500.00           $ 24.04
Common Stock             200,000(3)               $ 1.07                $214,000.00           $ 63.13
Common Stock             180,000(4)               $.175                 $ 31,500.00           $  9.29
=====================================================================================================================
       TOTAL                                                            $327,000.00           $ 96.46
=====================================================================================================================
</TABLE>


(1)  Pursuant  to  Rule  416,  this  Registration  Statement  also  covers  such
     indeterminable  number of additional shares as may become issuable pursuant
     to terms designed to prevent  dilution  resulting from stock splits,  stock
     dividends or similar events.

                                      1

<PAGE>


(2)  Represents  Shares  issuable  under  Employee  Stock Option  Agreements  to
     William R. Stoddard, Durand Smith and Mondis Nkoy.

(3)  Represents  Shares  issuable  under  Employee  Stock Option  Agreements  to
     William R. Stoddard and John M. Williams

(4)  Represents shares issued to William R, Stoddard for wages. Estimated solely
     for the purpose of calculating the registration fee in accordance with Rule
     457(c)  under the  Securities  Act and based on the average of the high and
     low price per share of Cyclo3pss  Corporation,  Inc. Common Stock as quoted
     on the OTC Bulletin Board on April 25, 1999.


                                      2

<PAGE>



                               EXPLANATORY NOTE

     Pursuant to Rule 428(b) (1) under the  Securities  Act of 1933,  as amended
(the "Securities Act"), an Information  Statement will be distributed to William
Stoddard,  John  Williams,   Durand  Smith  and  Mondis  Nkoy  under  a  written
compensatory agreement. The Information Statement and the documents incorporated
by reference  in this  Registration  Statement  pursuant to Item 3 of Part II of
this  Form  S-8,  taken  together,   constitute  a  prospectus  that  meets  the
requirements of the Securities Act.

                      ------------------------------------


                                    PART I

             INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

Item 1. Plan Information

       Not required to be filed with this Registration Statement.

Item 2. Registrant Information and Employee Plan Annual Information

       Not required to be filed with this Registration Statement


                                    PART II

              INFORMATION REQUIRED IN THE REGISTRATION STATEMENT


ITEM 3.      Incorporation of Documents By Reference

       The  following   documents  filed  by  Cyclo3pss   Corporation  with  the
Securities and Exchange Commission as of their respective dates are incorporated
by reference in this registration statement:

             (a)  Registrant's  Annual Report on Form 10-KSB for the fiscal year
       ending  February  28,  1998,  filed  pursuant  to  Section  13(a)  of the
       Securities Exchange Act of 1934, as amended.

             (b)  Registrant's  quarterly  report on Form  10-QSB for the fiscal
       quarter ended November 30, 1998, and all other reports,  if any, filed by
       the  Registrant  pursuant  to  Section  13(a) or 15(d) of the  Securities
       Exchange Act of 1934 since the end of the fiscal year ended  February 28,
       1998.

             (c) The description of  Registrant's  common stock contained in the
       Registration Statement on Form 10-SB filed with the Commission on October
       26, 1993,  including  any  amendments or reports filed for the purpose of
       updating such description.

                                      3

<PAGE>



       All documents filed by the Registrant  pursuant to Sections 13(a),  13(c)
14 and  15(d)  of the  Securities  Exchange  Act of 1934  after  the date of the
Prospectus  which  is a part of this  Registration  Statement  and  prior to the
termination  of the offering of these shares of common  stock  offered  thereby,
shall  be  deemed  to be  incorporated  by  reference  and to be a  part  of the
Prospectus from the date of filing of such document.  Any statement contained in
a document  incorporated by reference herein or contained herein shall be deemed
to be modified or  superseded  to the extent  that a statement  herein,  or in a
document  subsequently   incorporated  by  reference  herein,  shall  modify  or
supersede such statement.  Any statement so modified or superseded  shall not be
deemed,  except  as so  modified  or  superseded,  to  constitute  a part of the
Prospectus.

ITEM 4.      Description of Securities

       Not applicable; the class of securities to be offered is registered under
Section 12 of the Securities Exchange Act of 1934, as amended.

ITEM 5.      Interests of Named Experts and Counsel

       Not applicable.

ITEM 6.      Indemnification of Directors and Officers

       As permitted by sections 102 and 145 of the Delaware General  Corporation
Law,  the  Registrant's  Certificate  of  Incorporation  eliminates a director's
personal  liability for monetary  damages to the Registrant and its stockholders
arising from a breach of alleged  breach of a director's  fiduciary  duty except
for  liability  under  section 174 of the Delaware  General  Corporation  Law or
liability for any breach of the director's  duty of loyalty to the Registrant or
its  stockholders,  for acts or  omissions  not in good  faith or which  involve
intentional misconduct or a knowing violation of law or for any transaction from
which the  director  derived an improper  personal  benefit.  The effect of this
provision in the Certificate of  Incorporation is to eliminate the rights of the
Registrant  and its  stockholders  (through  stockholders'  derivative  suits on
behalf of the  Registrant) to recover  monetary  damages  against a director for
breach of  fiduciary  duty as a  director  (including  breaches  resulting  from
negligent  or grossly  negligent  behavior)  except in the  situation  described
above.

       The  Registrant's  Certificate  of  Incorporation  and Bylaws provide for
indemnification  of  officers,  directors  and  employees,  and the  Company has
entered into an indemnification  agreement with each officer and director of the
Registrant  (an  "Indemnitee").   Under  the  Bylaws  and  such  indemnification
agreements,  the  Registrant  must indemnify an Indemnitee to the fullest extent
permitted by Delaware law for losses and expenses  incurred in  connection  with
actions in which the  Indemnitee is involved by reason of having been a director
or employee of the  Registrant.  The  Registrant  is also  obligated  to advance
expenses an  Indemnitee  may incur in  connection  with such actions  before any
resolution of the action, and the Indemnitee may sue to enforce his or her right
to indemnification or advancement of expenses.

       There is no litigation pending, and neither the Registrant nor any of its
directors know of any threatened  litigation,  which might result in a claim for
indemnification by any director or officer.

                                      4

<PAGE>



ITEM 7.      Exemption From Registration Claimed

       Not Applicable.

ITEM 8.      Exhibits

       The following exhibits are filed as part of this Registration Statement:

Exhibit
Number       Description

4.1  Employee Stock Option Agreement- William R. Stoddard -August 31, 1996

4.2  Employee Stock Option Agreement- John M. Williams -August 31, 1996

4.3. Employment Agreement - William R. Stoddard - August 31, 1997

4.4. Employment Agreement - Durand Smith- March 1, 1998

4.5. Employee Stock Option Agreement - Mondis Nkoy - May 31, 1997

4.6. Agreement (Regarding Shares in Lieu of Cash Salrary)- William R. Stoddard -
     April 15, 1999

5.1  Opinion Regarding Legality and Consent

23.1 Consent of Ernst & Young, LLP, independent auditors

25.1 Power of Attorney-Located on Signature Page


ITEM 9.  Undertakings

       (a) Rule 415.     The undersigned Registrant hereby undertakes:

       (1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:

             (i)   To include any Prospectus required by Section 10(a)(3) of the
       Securities Act of 1933;

             (ii) To reflect in the Prospectus any facts or events arising after
       the  effective  date of the  Registration  Statement  (or the most recent
       post-effective   amendment   thereof)  which,   individually  or  in  the
       aggregate, represent a fundamental change in the information set forth in
       the Registration Statement;

                                      5

<PAGE>



             (iii) To include any material  information with respect to the plan
       of distribution not previously disclosed in the Registration Statement or
       any material change to such information in the Registration Statement.

       Provided,  however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply
if the  information  required to be included in a post  effective  amendment  by
those  paragraphs  is  contained  in periodic  reports  filed by the  Registrant
pursuant to section 13 or section 15(d) of the  Securities  Exchange Act of 1934
that are incorporated by reference in this registration statement.

       (2)  That,  for the  purpose  of  determining  any  liability  under  the
Securities Act of 1933, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

       (3) To remove from registration by means of post-effective  amendment any
of the securities being registered which remain unsold at the termination of the
offering.

       (b) The undersigned  Registrant  hereby  undertakes that, for purposes of
determining  any liability  under the Securities  Act of 1933, as amended,  each
filing of the  Registrant's  annual report  pursuant to section 13(a) or section
15(d) of the Securities  Exchange Act of 1934, as amended (and, where applicable
each filing of an employee  benefit  plan's  annual  report  pursuant to section
15(d) of the Securities  Exchange Act of 1934) that is incorporated by reference
in the registration statement shall be deemed to be a new registration statement
relating to the securities offered therein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

       (c)  Insofar  as  indemnification   for  liabilities  arising  under  the
Securities Act of 1933, as amended, may be permitted to directors,  officers and
controlling persons of the Registrant pursuant to the foregoing  provisions,  or
otherwise, the Registrant has been advised that in the opinion of the Securities
and  Exchange  Commission  such  indemnification  is  against  public  policy as
expressed in the Act and is, therefore, unenforceable. In the event that a claim
for  indemnification  against  such  liabilities  (other than the payment by the
Registrant of expenses  incurred or paid by a director,  officer or  controlling
person of the  Registrant  in the  successful  defense  of any  action,  suit or
proceeding)  is  asserted  by a  director,  officer  or  controlling  person  in
connection with the securities being registered,  the Registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of  appropriate  jurisdiction  the  question  of whether  such
indemnification by it is against public policy as expressed in the Act and shall
be governed by the final adjudication of such issue.



                                      6

<PAGE>







                                  SIGNATURES

      Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on FORM S-8 and has  duly  caused  this  Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized,  in the City of Salt  Lake,  State  of Utah,  on the 6th day of May,
1999.

CYCLO3PSS CORPORATION



By:  /s/ William R. Stoddard                    By:  /s/ Mondis Nkoy           
   ----------------------------                 -------------------------------
   William R. Stoddard                           Mondis Nkoy
   Chief Executive Officer                      Principal Financial Officer

      KNOW ALL MEN BY THESE  PRESENTS,  that each person who  signature  appears
below  constitutes  and appoints  each of William R. Stoddard and Mondis Nkoy as
true and lawful  attorney-in-fact and agent, each acting alone, with full powers
of substitution and  restitution,  for him and his name, place and stead, in any
and  all  capacities,  to  sign  any and  all  amendments  to this  registration
statement,  and to file the same, with all exhibits thereto, and other documents
in connection  therewith,  with the Securities and Exchange  Commission,  and to
make any and all state  securities  law or blue sky filings,  granting unto said
attorney-in-fact  and agents,  each acting alone, full power and authority to do
and perform each and every act and thing  requisite  and necessary to be done in
and about the  premises,  as fully for all intents  and  purposes as he might or
could  do  in  person,   hereby   ratifying   and   confirming   all  that  said
attorney-in-fact   and  agents,   each  acting  alone,   or  his  substitute  or
substitutes, may lawfully do or cause to be done by virtue hereof.

      Pursuant  to  the  requirements  of  the  Securities  Act  of  1933,  this
Registration  Statement  has  been  signed  by  the  following  persons  in  the
capacities and on the dates indicated.

      Date                 Title                      Signature

May 6, 1999              Chief Executive             /s/ William R. Stoddard
                         Officer                     William R. Stoddard

May 6, 1999              Director                    /s/ Michael Lakis
                                                     Michael Lakis

April 27, 1999           Director                    /s/ Robert Dunn         
                                                     Robert Dunn

April 26, 1999           Director                    /s/ Steve Sarich, Jr.   
                                                     Steve Sarich, Jr.

April 28, 1999           Director                    /s/ Richard Nelson     
                                                     Richard Nelson




                                      7

<PAGE>









                                 EXHIBIT INDEX

Exhibit
Number            Description

4.1  Employee Stock Option Agreement- William R. Stoddard -August 31, 1996

4.2  Employee Stock Option Agreement- John M. Williams -August 31, 1996

4.3. Employment Agreement - William R. Stoddard - August 31, 1997

4.4. Employment Agreement - Durand Smith- March 1, 1998

4.5. Employee Stock Option Agreement - Mondis Nkoy - May 31, 1997

4.6. Agreement (Regarding Shares in Lieu of Cash Salrary)- William R. Stoddard -
     April 15, 1999

5.1  Opinion Regarding Legality and Consent

23.1 Consent of Ernst & Young, LLP, independent auditors

25.1 Power of Attorney-Located on Signature Page


                                      8




             STOCK OPTION AGREEMENT FOR THE YEAR BEGINNING 9/1/96
                 PURSUANT TO AN EMPLOYMENT AGREEMENT BETWEEN
           WILLIAM R. STODDARD AND CYCLO3PSS MEDICAL SYSTEMS, INC.



     THIS AGREEMENT is effective as of the 31st day of August,  1996 (the "Grant
Date"),  by and between  CYCLO3PSS  MEDICAL  SYSTEMS,  INC. (the  "Company") and
William R. Stoddard (the "0ptionee");

                                 WITNESSETH:

      WHEREAS,  0ptionee is the Vice President and Secretary of the Company, and
the Company and its board of directors  consider it  desirrable  and in its best
interests that Optionee be given an inducement to remain in the Company's employ
and to acquire a proprietary  interest in the Company, and an added incentive to
advance the interests of the Company by possessing an option to purchase  shares
of the Company's common stock (the "Stock"), and

      WHEREAS,  the  compensation  committee  of the Board of  Directors  of the
Company  (the  "Committee"  and  the  Board  of  Directors  of the  Company  has
authorized  the grant to  Optionee  of a stock  option  authorizing  0ptionee to
purchase shares of common stock of the Company (the "Common Stock"); and

     WHEREAS,  the Company and 0ptionee wish to further  confirm and outline the
terms and conditions of the option;

       NOW,  THEREFORE,  in  consideration  of the  mutual  covenants  contained
herein, it is hereby agreed between the parties hereto as follows:

      1. Grand of Option.  Subject to the terms,  restrictions,  limitations and
conditions stated herein and in the prospectus and the registration statement to
be filed  registering  the shares  underlying  this option,  the Company  hereby
grants to the  0ptionee an option (the  "Option") to purchase all or any part of
100,000  post-split shares (after the 1:5 reverse stock split approved on August
26, 1993 and  effective  September 8 1993) of common  stock of the Company  (the
"Shares" ).

      2.    Term and  Exercise  of  Option.  Subject to the  provisions  of this
            Agreement:  (a) This option may be  exercised by the optionee at any
            time during the 0ption
      Period,  as defined in Section 4 hereof  which  provides  that none of the
      Options  granted herein will be exercisable  until August 31 1997. At that
      date, all of the options  granted  herein will then be exersisable  unless
      the  ootionee's  employment  with the Company has  terminated  prior to' p
      August 31, 1997, in which event the number of options  exercisable will be
      reduced by 8,333 shares for each month or part thereof between the date of
      termination and August 31, 1997. However, the intervenin death of 0ptionee
      before

                                      9

<PAGE>



      August 31, 1997 will remove this continued  employment  condition from all
      options granted herein.

            (b) Subject to Section 7 hereof,  the Option may be  exercised  with
      respect the exercisable portion thereof at any time after August 3 l, 1997
      and prior to the  expiration  date by the delivery to the Company,  at its
      principal place of business, of:

      (i) a written notice of exercise in substantially the form attached hereto
      as Exhibit 1 , which shall be actually delivered to the Company no earlier
      than  thirty  (30) days and no later than ten ( 10) days prior to the date
      upon which Optionee desires to exercise all or a portion of 0ption;

      (ii)  payment to the Company of the Exercise  Price,  defined in Section 3
      below,multiplied  by the nurmber of shares being  purchased (the "Purchase
      Price") in the manner provided in Subsection (c) hereof; and

      (iii)  payment  of all  withholding  tax  obligations,  if  any,  (whether
      federal, state or local) imposed by reason of the exercise of the Option.

      Upon  receipt of such  notice,  receipt of payment in full of the Purchase
      Price,  and receipt of payment of any withholding tax obligations due, the
      Company shall cause to be issued an unrestricted  certificate representing
      the Shares purchased.

            (c) The Purchase  Price and  withholding  tax  obligations,  if any,
      shall be paid in full upon the  exercise of an Option and no Shares  shall
      be issued or delivered until full payment therefor has been made.  Payment
      of the Purchase Price for Shares purchased  pursuant to the exercise of an
      Option and any tax withholding obligations shall be made:

      (i) in cash or by certified check;or

      (ii) by delivery  to the Company of a number of shares of common  stock of
      the Company  which have been owned by the optionee for at least six months
      prior to the date of the  Option's  exercise  and which have a fair market
      value on the date of exercise, as determined by the Compensation Committee
      in its sole  discretion,  which is either equal to or which in combination
      with cash is equal to the purchase price; or

      (iii) by receipt of the  purchase  price in cash from a broker,  dealer or
      other  "creditor"  as  defined  by  Regulation  "T" issued by the Board of
      Governors of the Federal Reserve System following delivery by the optionee
      to the committee of instructions regarding delivery to such broker, dealer
      or other  "creditor"of  that number of shares of common stock with respect
      to which the Option is exercised.
 .
      3. Exercise  Price.  The exercise price for each share of Common Stock for
which the 0ption is exercised shall be $ 1.07 per share subject to adjustment as
set forth in Section 7 hereof (the "Exercise Price"). Said Exercise Price is not
less than l00% of the fair  market  value of such stock as of the date of action
by the Compensation Committee.

                                      10

<PAGE>







      4. Term and Termination of 0ption.  Except as otherwise  provided  herein,
the term of the option (the "Option  Period")  shall  commence three years after
the Grant Date,  provided that the Optionee continues to serve as an employee of
the  Company  for at least  three (3) years  after  the  Grant  Date,  and shall
terminate on the eighth  anniversary of the Grant Date.  Upon  expiration of the
Option  Period  this  Option,  and all  unexercised  rights  granted to Optionee
hereunder, shall terminate and thereafter be null and void.

      5. Rights as  Shareholders.  Until the stock  certificates  reflecting the
Shares  accruing to the Optionee  upon  exercise of the Option are issued to the
Optionee,  the Optionee  shall have no rights as a  shareholder  with respect to
such  Shares.   The  Company  shall  make  no  adjustment   for  any  dividends,
distributions or other rights on or with respect to Shares purchased pursuant to
the  Option  for which the record  date is prior to the  issuance  of that stock
certificate.

      6.  Restriction  on Transfer  of Option.  The Option  evidenced  hereby is
nontransferable other than by last will and testament or the laws of descent and
distribution, and, shall be exercisable during the lifetime of the Optionee only
by  the  Optionee  (or  in  the  event  of  his  disability,   by  his  personal
representative) and after his death, only by his personal representative.

      7.  Change in  Capitalization,  Change in  Control,  etc. If the number of
shares of the Common  Stock of the Company  shall be  increased  or reduced by a
stock  split  (other than the 1:5  reverse  stock split  approved on 8/26/93 and
effective 9/8/93 which has already been given effect herein), payment of a stock
dividend,  a subdivision or combination of shares,  reclassification,  merger or
consolidation, or similar capital adjustment, an appropriate adjustment shall be
made by the  Committee  in the number and kind of shares as to which the Option,
or the portion thereof then unexercised,  shall be or become exercisable, to the
end that the Optionee's proportionate interest shall be maintained as before the
change in the total price applicable to the unexercisable  portion of the Option
and with a corresponding  adjustment in the Exercise Price. All adjustments made
by the Committee under this Section shall be conclusive.

      If the  Company  shall  be the  surviving  corporation  in any  merger  or
consolidation,   recapitalization,   reclassification   of  shares  or   similar
reorganization,  an  appropriate  adjustment  shall be made with  respect to the
Shares so that the Optionee  shall be entitled to purchase at the same times and
upon the same terms and conditions as are then provided by this  Agreement,  the
number and class of securities to which a holder of the number of Shares subject
to the  Agreement  at the time of the  transaction  would have been  entitled to
receive as a result of such transaction,  with any corresponding adjustment made
to the Exercise Price.

      In the event of (a) a dissolution  or  liquidation  of the Company;  (b) a
merger of the Company  into another  corporation,  or any  consolidation,  share
exchange, combination,  reorganization, or like transaction in which the Company
is not the  survivor;  (c) a sale or transfer  (other  than as security  for the
Company's  obligations) of at least a majority if the assets of the Company;  or
(d) a sale or transfer of 5O% or more of the issued and outstanding shares of

                                      11

<PAGE>



Common Stock by the holders  thereof in a single  transaction  or in a series of
related transactions,  the 0ption shall become immediately exercisable as to all
Shares  subject  thereto to the extent it has not already become so. The Company
shall use its best  efforts  to provide  Optionee  with  written  notice of such
transaction at least thirty (30) days prior to the date of its consummation

      8.  Legend  on Stock  Certificates.  Until  and  unless  the  registration
statement  to be filed  .which is intended  to register  the shares to be issued
pursuant  to  the  exercise  of  the  options   granted   herein  is  effective,
Certificates evidencing Common Stock to be distributed pursuant to the Agreement
and  the  Plan  shall,  to the  extent  appropriate  at  the  time,  have  noted
conspicuously  on the  certificates an appropriate  restrictive  legend which is
intended to give all persons  full notice of the  existence  of any  conditions,
restrictions,  rights and obligations related to the free transferability of the
shares issued.

      9. Governing  Laws. This Agreement  shall be construed,  administered  and
enforced  according  to the laws of the  State of Utah;  provided,  however,  no
option  may be  exercised  except  in the  reasonable  judgment  of the Board of
Directors,  in compliance with exemptions under applicable state securities laws
of the  state in  which  the  Optionee  resides,  and/or  any  other  applicable
securities laws.

      10.  Successors.  This  Agreement  shall be binding upon and insure to the
benefits of the heirs, legal  representatives,  successors and permitted assigns
of the parties.

      1l. Notice.  Except as otherwise  specified herein,  all notices and other
communications under this Agreement shall be in writing and shall deemed to have
been given if personally  delivered or if sent by registered or certified United
States  mail,  return  receipt  requested,  postage  prepaid,  addressed  to the
proposed  recipient at the last known  address of the  recipient.  Any party may
designate  any other  address to which notices shall be sent by giving notice of
the address to the other parties in the same manner as provided herein.

      12.  Severabitity.  In the event that any one or more of the provisions or
portion  thereof  contained in this Agreement shall for any reason be held to be
invalid,  illegal or unenforceable in any respect, the same shall not invalidate
or otherwise affect any other  provisions of this Agreement,  and this Agreement
shall be  construed  as if the invalid,  illegal or  unenforceable  provision or
portion thereof had never been contained herein.

     l3. Entire Agreement. Subject to the terms and conditions of the Plan, this
Agreement expresses the entire understanding and agreement of the parties.  This
Agreement  may be executed in two or more  counterparts,  each of which shall be
deemed  an  original  but  all of  which  shall  constitute  one  and  the  same
instruments.

      14. Violation. Any transfer, pledge, sale, assignment, or hypothecation of
the Option or any  portion  thereof  shall be a  violation  of the terms of this
Agreement and shall be void without effect.

     l5.  Headings.  Paragraph  headings  used  herein  are for  convenience  of
reference only and shall not be considered in construing this Agreement.

                                      12

<PAGE>



      16. Specific Performance. In the event of any actual or threatened default
in, or breach of, any of the terms, conditions and provisions of this Agreement,
the party or parties who are thereby  aggrieved shall have the right to specific
performance  and injunction in addition to any and all other rights and remedies
at law or in equity, and all such rights and remedies shall be cumulative.

      17. No Emplyment Rights Created. Neither the establishment of the Plan nor
the grant of the option  hereunder shall be construed as giving the Optionee the
right to continued employment with the Company or a subsidiary.

      IN WITNESS WHEREOF, the parties have executed and sealed this Agreement on
the day and year first set forth above.

                                    CYCLO3PSS MEDICAL SYSTEMS, INC.



                                    /s/ John M. Williams                    
                                    By:    John M. Williams
                                    Title: CEO, President & Chairman


                                    OPTIONEE :



                                     /s/ William R. Stoddard                
                                    William R. Stoddard

                                      13






             STOCK OPTION AGREEMENT FOR THE YEAR BEGINNING 9/1/96
                 PURSUANT TO AN EMPLOYMENT AGREEMENT BETWEEN
             JOHN M. WILLIAMS AND CYCLO3PSS MEDICAL SYSTEMS, INC.



      THIS AGREEMENT is effective as of the 31st day of August, 1996 (the "Grant
Date"), by and between CYCLO3PSS MEDICAL SYSTEMS,  INC. (the "Company") and John
M.
Williams (the "0ptionee");

                                 WITNESSETH:

      WHEREAS, 0ptionee is the President and CEO of the Company, and the Company
and its board of directors consider it desirrable and in its best interests that
Optionee be given an inducement to remain in the Company's employ and to acquire
a  proprietary  interest in the Company,  and an added  incentive to advance the
interests  of the  Company by  possessing  an option to  purchase  shares of the
Company's common stock (the "Stock"), and

      WHEREAS,  the  compensation  committee  of the Board of  Directors  of the
Company  (the  "Committee"  and  the  Board  of  Directors  of the  Company  has
authorized  the grant to  Optionee  of a stock  option  authorizing  0ptionee to
purchase shares of common stock of the Company (the "Common Stock"); and

     WHEREAS,  the Company and 0ptionee wish to further  confirm and outline the
terms and conditions of the option;

       NOW,  THEREFORE,  in  consideration  of the  mutual  covenants  contained
herein, it is hereby agreed between the parties hereto as follows:

      1. Grand of Option.  Subject to the terms,  restrictions,  limitations and
conditions stated herein and in the prospectus and the registration statement to
be filed  registering  the shares  underlying  this option,  the Company  hereby
grants to the  0ptionee an option (the  "Option") to purchase all or any part of
100,000  post-split shares (after the 1:5 reverse stock split approved on August
26, 1993 and  effective  September 8 1993) of common  stock of the Company  (the
"Shares" ).

      2.    Term and  Exercise  of  Option.  Subject to the  provisions  of this
            Agreement:  (a) This option may be  exercised by the optionee at any
            time during the 0ption
      Period,  as defined in Section 4 hereof  which  provides  that none of the
      Options  granted herein will be exercisable  until August 31 1997. At that
      date, all of the options  granted  herein will then be exersisable  unless
      the  optionee's  employment  with the Company has  terminated  prior to' p
      August 31, 1997, in which event the number of options  exercisable will be
      reduced by 8,333 shares for each month or part thereof between the date of
      termination and August 31, 1997. However, the intervenin death of 0ptionee
      before  August 31, 1997 will remove this  continued  employment  condition
      from all options granted herein.

                                      14

<PAGE>


            (b) Subject to Section 7 hereof,  the Option may be  exercised  with
      respect the exercisable portion thereof at any time after August 3 l, 1997
      and prior to the  expiration  date by the delivery to the Company,  at its
      principal place of business, of:

      (i) a written notice of exercise in substantially the form attached hereto
      as Exhibit 1 , which shall be actually delivered to the Company no earlier
      than  thirty  (30) days and no later than ten ( 10) days prior to the date
      upon which Optionee desires to exercise all or a portion of 0ption;

      (ii)  payment to the Company of the Exercise  Price,  defined in Section 3
      below,multiplied  by the nurmber of shares being  purchased (the "Purchase
      Price") in the manner provided in Subsection (c) hereof; and

      (iii)  payment  of all  withholding  tax  obligations,  if  any,  (whether
      federal, state or local) imposed by reason of the exercise of the Option.

      Upon  receipt of such  notice,  receipt of payment in full of the Purchase
      Price,  and receipt of payment of any withholding tax obligations due, the
      Company shall cause to be issued an unrestricted  certificate representing
      the Shares purchased.

            (c) The Purchase  Price and  withholding  tax  obligations,  if any,
      shall be paid in full upon the  exercise of an Option and no Shares  shall
      be issued or delivered until full payment therefor has been made.  Payment
      of the Purchase Price for Shares purchased  pursuant to the exercise of an
      Option and any tax withholding obligations shall be made:

      (i) in cash or by certified check;or

      (ii) by delivery  to the Company of a number of shares of common  stock of
      the Company  which have been owned by the optionee for at least six months
      prior to the date of the  Option's  exercise  and which have a fair market
      value on the date of exercise, as determined by the Compensation Committee
      in its sole  discretion,  which is either equal to or which in combination
      with cash is equal to the purchase price; or

      (iii) by receipt of the  purchase  price in cash from a broker,  dealer or
      other  "creditor"  as  defined  by  Regulation  "T" issued by the Board of
      Governors of the Federal Reserve System following delivery by the optionee
      to the committee of instructions regarding delivery to such broker, dealer
      or other  "creditor"of  that number of shares of common stock with respect
      to which the Option is exercised.
 .
      3. Exercise  Price.  The exercise price for each share of Common Stock for
which the 0ption is exercised shall be $ 1.07 per share subject to adjustment as
set forth in Section 7 hereof

                                      15

<PAGE>



(the  "Exercise  Price").  Said Exercise Price is not less than l00% of the
fair  market  value of such  stock as of the date of action by the  Compensation
Committee.

      4. Term and Termination of 0ption.  Except as otherwise  provided  herein,
the term of the option (the "Option  Period")  shall  commence three years after
the Grant Date,  provided that the Optionee continues to serve as an employee of
the  Company  for at least  three (3) years  after  the  Grant  Date,  and shall
terminate on the eighth  anniversary of the Grant Date.  Upon  expiration of the
Option  Period  this  Option,  and all  unexercised  rights  granted to Optionee
hereunder, shall terminate and thereafter be null and void.

      5. Rights as  Shareholders.  Until the stock  certificates  reflecting the
Shares  accruing to the Optionee  upon  exercise of the Option are issued to the
Optionee,  the Optionee  shall have no rights as a  shareholder  with respect to
such  Shares.   The  Company  shall  make  no  adjustment   for  any  dividends,
distributions or other rights on or with respect to Shares purchased pursuant to
the  Option  for which the record  date is prior to the  issuance  of that stock
certificate.

      6.  Restriction  on Transfer  of Option.  The Option  evidenced  hereby is
nontransferable other than by last will and testament or the laws of descent and
distribution, and, shall be exercisable during the lifetime of the Optionee only
by  the  Optionee  (or  in  the  event  of  his  disability,   by  his  personal
representative) and after his death, only by his personal representative.

      7.  Change in  Capitalization,  Change in  Control,  etc. If the number of
shares of the Common  Stock of the Company  shall be  increased  or reduced by a
stock  split  (other than the 1:5  reverse  stock split  approved on 8/26/93 and
effective 9/8/93 which has already been given effect herein), payment of a stock
dividend,  a subdivision or combination of shares,  reclassification,  merger or
consolidation, or similar capital adjustment, an appropriate adjustment shall be
made by the  Committee  in the number and kind of shares as to which the Option,
or the portion thereof then unexercised,  shall be or become exercisable, to the
end that the Optionee's proportionate interest shall be maintained as before the
change in the total price applicable to the unexercisable  portion of the Option
and with a corresponding  adjustment in the Exercise Price. All adjustments made
by the Committee under this Section shall be conclusive.

      If the  Company  shall  be the  surviving  corporation  in any  merger  or
consolidation,   recapitalization,   reclassification   of  shares  or   similar
reorganization,  an  appropriate  adjustment  shall be made with  respect to the
Shares so that the Optionee  shall be entitled to purchase at the same times and
upon the same terms and conditions as are then provided by this  Agreement,  the
number and class of securities to which a holder of the number of Shares subject
to the  Agreement  at the time of the  transaction  would have been  entitled to
receive as a result of such transaction,  with any corresponding adjustment made
to the Exercise Price.

      In the event of (a) a dissolution  or  liquidation  of the Company;  (b) a
merger of the Company  into another  corporation,  or any  consolidation,  share
exchange, combination,  reorganization, or like transaction in which the Company
is not the  survivor;  (c) a sale or transfer  (other  than as security  for the
Company's  obligations) of at least a majority if the assets of the Company;  or
(d) a sale or  transfer of 50% or more of the issued and  outstanding  shares of
Common Stock by the holders  thereof in a single  transaction  or in a series of
related transactions,

                                      16

<PAGE>



the 0ption shall become immediately exercisable as to all Shares subject thereto
to the  extent it has not  already  become so.  The  Company  shall use its best
efforts to provide  Optionee with written  notice of such  transaction  at least
thirty (30) days prior to the date of its consummation

      8.  Legend  on Stock  Certificates.  Until  and  unless  the  registration
statement  to be filed  .which is intended  to register  the shares to be issued
pursuant  to  the  exercise  of  the  options   granted   herein  is  effective,
Certificates evidencing Common Stock to be distributed pursuant to the Agreement
and  the  Plan  shall,  to the  extent  appropriate  at  the  time,  have  noted
conspicuously  on the  certificates an appropriate  restrictive  legend which is
intended to give all persons  full notice of the  existence  of any  conditions,
restrictions,  rights and obligations related to the free transferability of the
shares issued.

      9. Governing  Laws. This Agreement  shall be construed,  administered  and
enforced  according  to the laws of the  State of Utah;  provided,  however,  no
option  may be  exercised  except  in the  reasonable  judgment  of the Board of
Directors,  in compliance with exemptions under applicable state securities laws
of the  state in  which  the  Optionee  resides,  and/or  any  other  applicable
securities laws.

      10.  Successors.  This  Agreement  shall be binding upon and insure to the
benefits of the heirs, legal  representatives,  successors and permitted assigns
of the parties.

      1l. Notice.  Except as otherwise  specified herein,  all notices and other
communications under this Agreement shall be in writing and shall deemed to have
been given if personally  delivered or if sent by registered or certified United
States  mail,  return  receipt  requested,  postage  prepaid,  addressed  to the
proposed  recipient at the last known  address of the  recipient.  Any party may
designate  any other  address to which notices shall be sent by giving notice of
the address to the other parties in the same manner as provided herein.

      12.  Severabitity.  In the event that any one or more of the provisions or
portion  thereof  contained in this Agreement shall for any reason be held to be
invalid,  illegal or unenforceable in any respect, the same shall not invalidate
or otherwise affect any other  provisions of this Agreement,  and this Agreement
shall be  construed  as if the invalid,  illegal or  unenforceable  provision or
portion thereof had never been contained herein.

     l3. Entire Agreement. Subject to the terms and conditions of the Plan, this
Agreement expresses the entire understanding and agreement of the parties.  This
Agreement  may be executed in two or more  counterparts,  each of which shall be
deemed  an  original  but  all of  which  shall  constitute  one  and  the  same
instruments.

      14. Violation. Any transfer, pledge, sale, assignment, or hypothecation of
the Option or any  portion  thereof  shall be a  violation  of the terms of this
Agreement and shall be void without effect.

     l5.  Headings.  Paragraph  headings  used  herein  are for  convenience  of
reference only and shall not be considered in construing this Agreement.


                                      17

<PAGE>



      16. Specific Performance. In the event of any actual or threatened default
in, or breach of, any of the terms, conditions and provisions of this Agreement,
the party or parties who are thereby  aggrieved shall have the right to specific
performance  and injunction in addition to any and all other rights and remedies
at law or in equity, and all such rights and remedies shall be cumulative.

      17. No Emplyment Rights Created. Neither the establishment of the Plan nor
the grant of the option  hereunder shall be construed as giving the Optionee the
right to continued employment with the Company or a subsidiary.

      IN WITNESS WHEREOF, the parties have executed and sealed this Agreement on
the day and year first set forth above.

                            CYCLO3PSS MEDICAL SYSTEMS, INC.


                            /s/ William R. Stoddard 
                            By:  William R. Stoddard
                                 Title: Vice President


                              OPTIONEE:



                              /s/ John M. Williams 
                              John M. Williams

                                      18




                              EMPLOYMENT CONTRACT

      AN AGREEMENT made on August 31, 1997, between WILLIAM R. STODDARD residing
in Salt  Lake  City,  Utah,  herein  referred  to as  "STODDARD"  and  CYCLO3PSS
CORPORATION, a Delaware Corporation,  with business offices located at 3646 West
2100 South, Salt Lake City, Utah, herein referred to as "CYCLO3PSS".

      In  consideration  of the mutual  covenants  and  promises  of the parties
hereto, CYCLO3PSS and STODDARD agree as follows:

      SECTION ONE - EMPLOYMENT:  CYCLO3PSS employs STODDARD to act as President,
Chief  Executive  Officer  and  Chairman  of the  board  for  CYCLO3PSS  and its
subsidiary  corporations,  and STODDARD  accepts such employment with CYCLO3PSS,
subject to the terms and conditions of this agreement.

      SECTION TWO - TERM OF EMPLOYMENT: The effective term of this agreement and
the employment hereunder shall commence on September l, 1997, and continue until
August 31, 2000.

      SECTION THREE - DUTIES OF STODDARD: STODDARD will serve
CYCLO3PSS  to the  best of his  ability  under  the  direction  of the  board of
directors of CYCLO3PSS.  STODDARD shall devote such of his time and energy as is
necessary to timely  complete the  services and duties  contemplated  under this
agreement.

      SECTION FOUR - REGULAR COMPENSATION: STODDARD' S salary shall be
at the rate of One  Hundred  and  Fifty  Thousand  ($  150,000.00)  dollars  per
calendar year, payable semi-monthly, during the life of this agreement.

      SECTION FIVE - INCENTIVE STOCK OPTION:  In addition to the compensation as
described  above,  and as a further  incentive  for  STODDARD  to  continue  his
employment throughout the period defined above,  CYCLO3PSS agrees to, and hereby
grants to STODDA.RD, options for the purchase of FOUR HUNDRED AND FIFTY THOUSAND
SHA.RES  (450,000) of newly issued  restricted  common stock in concert with the
execution  of this  Contract.  These  options are  exercisable  at a rate of ONE
HUNDRED  AND FIFTY  THOUSAND  SHARES (l 50,000)  per year,  for each year of the
THREE YEAR (3yr) period of employment  as defined in the  Contract.  The options
are considered  earned monthly and are exercisable at the end of each employment
year and are  conditioned  only by section twelve of this Contract.  The options
are non-transferable  other than by will or the law of descent and distribution,
and expire upon the FIVE YEAR (5yr) anniversary of the date on which they become
exercisable.

     SECTION SIX - PRICE AND  VALUATION  OF THE  OPTIONED  SHARES:  The optioned
shares are deemed granted upon the execution of this  Employment  Contract.  The
options are granted at the current  fair  market  value of the  Companys  common
stock,  which has been  determined by Board of Directors of the Company to be 90
cents ($0.90) per share. Said

                                      19

<PAGE>



excercise  price is the average  closing bid for such said stock during the last
five days of August, 1997.

      SECTION  SEVEN - HEALTH  CARE  INSURANCE  BENEFITS:  It is the  intent  of
CYCLO3PSS to provide STODDARD and his dependants with health insurance  coverage
on a plan specific to key  executive  personnel.  CYCLO3PSS  shall have complete
descretion in choosing the type of health insurance plan provided  STODDA.RD and
in choosing the  insurance  carrier and extent of insurance  coverage,  provided
that such health insurance plan will include hospital, maternity, major medical,
and  dental  coverage  for  STODDARD  and his  dependants.  In the  event  it is
determined that establishing such an executive plan is inconsistent with federal
or state statutes.  CYCLO3PSS will provide the same health insurance benefits to
STODDARD that are provided to other employees.

      SECTION  EIGHT - MOVING  EXPENSES:  In the event  STODDARD  is required by
CYCLO3PSS to move his  residence  outside of the State of Utah,  STODDARD  shall
receive  towards any moving  expenses the amount actually spent for moving vans,
storage of goods in transit,  any sales  commission  on the sa.le of STODDARD' S
present residence, and all motel and hotel room expense.

      SECTION NINE - REIMBURSEMENT FOR EXPENSES: STODDARD shall be
authorized to incur reasonable  expenses on behalf of CYCLO3PSS  including,  but
not limited to, expenses for entertainment, travel, management seminars, related
travel and related use of the telephone.  CYCLO3PSS shall reimburse STODDARD for
reasonable  out-of pocket  expenses which STODDARD may incur in connection  with
his services for CYCLO3PSS contemplated herein,  provided that STODDARD presents
appropriate vouchers evidencing any such expenses to CYCLO3PSS.

      SECTION TEN - STODDARD'S SERVICE AS DIRECTOR: STODDARD hereby
consents to serve, if duly elected, as a director of CYCLO3PSS or any subsidiary
or corporation affiliated with CYCLO3PSS. However, STODDARD' S employment during
the  employment  period as defined above is not  conditioned  by, nor contingent
upon STODDARD'S participation as a member of the Board of Directors.

      SECTION ELEVEN - INDEMNIFICATION OF STODDARD: CYCLO3PSS shall
indemnify  STODDARD to the full extent  permitted  by law against all  expenses,
attorney's fees, judgments,  fines and amounts paid in settlement,  actually and
reasonably  incurred by STODDARD in connection with any  threatened,  pending or
completed action, suit or proceeding, whether civil, criminal, administrative or
investigative,  incurred by STODDARD in  connection  with any act or omission by
STODDARD  occasioned under this agreement,  provided that he acted in good faith
and in a manner  he  reasonably  believed  to be in or not  opposed  to the best
interest of CYCLO3PSS and provided, with respect to any criminal action, that he
did not have reasonable cause to believe his conduct was unlawful.

     SECTION TWELVE - TERMINATION: This agreement may be terminated by CYCLO3PSS
for cause only. Cause shall be defined as fraud, misappropriation or intentional
material  damage  to  the  property  or  business  of  CYCLO3PSS,  or  by  board
determination of

                                      20

<PAGE>



inadequate  performance.  STODDARD may cancel this  agreement on Sixty (60) days
written notice for any reason.  If CYCLO3PSS  terminates this agreement  without
cause,  CYCLO3PSS  shall  pay to  STODDARD,  an  amount  equal to the  remaining
compensation  set  forth  in  Section  Four  and  Five  hereof  from the date of
termination to the expiration  date of this  agreement.  If STODDARD  terminates
this agreement,  or if CYCLO3PSS  terminates  this Contract for cause,  STODDARD
will  receive  only  that  compensation  earned  by him up to the  point  of his
termination  including  stock  options  and  bonuses  then  due as set  forth in
sections Four and Five, with the non-competition  and non-disclosure  provisions
of Section Thirteen remaining in effect  notwithstanding the termination of this
agreement.

      SECTION THIRTEEN - NON-COMPETITION AFTER TERMINATION:
STODDARD  agrees that in addition  to any other  limitation,  for a period of 24
months after the termination of his employment  hereunder,  and unless otherwise
specified herein, he will not directly or indirectly engage in, or in any manner
be connected with or employed by any person,  firm or corporation in competition
with  CYCLO3PSS  or any of its  subsidiaries,  or engaged in  providing  similar
products  and  services  as  CYCLO3PSS  or any of its  subsidiaries,  within the
territorial limits of the United States of America.

      SECTION FOURTEEN - USE OF CONFIDENTIAL INFORMATION:
STODDARD  recognizes  and  acknowledges  that he will  have  access  to  certain
confidential  information  of  CYCLO3PSS  or other  division  or  subsidiary  of
CYCLO3PSS and that such  information  constitutes  valuable,  special and unique
property of CYCLO3PSS and such other entities.  STODDARD agrees that in addition
to any other  limitation,  regardless of the circumstances of the termination of
employment, he will not communicate to any person, firm, or corporation any such
confidential  information relating to any product,  patent,  patent pending, FDA
Certification,  license,  certificate,  design, customer lists, prices, secrets,
advertising,  or any confidential  knowledge or secrets which he might from time
to  time  acquire  with  respect  to the  business  of  CYCLO3PSS  or any of its
subsidiaries,  for  a  period  of  five  years  after  termination  or  whenever
information becomes available to the public, whichever comes first.

      SECTION  FIFTEEN  -  COMMUNICATIONS  TO  CYCLO3PSS:  From  the  time  this
agreement  commences until the termination  thereof,  STODDARD shall communicate
and channel to CYCLO3PSS all knowledge,  business and customer contracts and any
other matters of information  which could concern or be in any way beneficial to
the business of  CYCLO3PSS,  whether  acquired by STODDARD  before or during the
terms of this  agreement,  provided,  however,  that nothing  hereunder shall be
construed as requiring  such  communications  where the  information is lawfully
protected  from  disclosure  as a  trade  secret  of a  third  party.  Any  such
information  communicated  to  CYCLO3PSS  as  aforesaid  shall be and remain the
property  of  CYCLO3PSS,  notwithstanding  the  subsequent  termination  of this
agreement.

      SECTION SIXTEEN - BINDING  EFFECT:  This agreement shall be binding on and
shall insure to the benefit of CYCLO3PSS, or any successor (s) of CYCLO3PSS, and
the  personal  representatives  of  STODDA.RD.  CYCLO3PSS  may assign all of its
interest in this agreement,  subject to all the obligations of CYCLO3PSS, to any
third-party  interested  in  taking  over the  capital  stock  and  property  of
CYCLO3PSS,   and  STODDARD  will  fulfill  for  such  corporation  any  and  all
obligations  required under this  agreement.  In the event any such  third-party
taking

                                      21

<PAGE>



over the capital stock and/or  property of CYCLO3PSS  terminates this employment
agreement for any reason other than cause as defined in Section  Twelve  hereof,
STODDARD shall be entitled to his full  compensation  hereunder  remaining under
the THREE (3) year terms of this  employment  agreement,  including  all bene~ts
and/or rights set forth in Sections Four, Five, Seven, Eight and Nine hereof.

      SECTION SEVENTEEN - LAW TO GOVERN CONTRACT: This agreement shall
be governed by the law of the State of Utah.

      SECTION EIGHTEN - MISCELLANEOUS: In the event a provision of this
agreement shall be construed  invalid or  unenforceable  by a court of competent
jurisdiction,   this  agreement  shall  be  construed  as  if  such  invalid  or
unenforceable provisions were omitted.

     In Witness  Whereof,  the parties have executed this  agreement the day and
year first above written. 

                            /s/ William R. Stoddard 
                               WILLIAM R. STODDARD

                            CYCLO3PSS CORPORATION
                            Under Authority of the Board of Directors ;


                            By: /s/ Steve Sarich, Jr.                     
                                Member of the Board and of
                                The Executive Compensation
                                Committee


Attest:




___________________














                                      22

<PAGE>



                              AMENDMENT NO. 1 TO

                              EMPLOYMENT CONTRACT

      The  undersigned  agree that  Section  Six of the  Employment  Contract is
hereby amended to reduce the exercise price of the option shares from $1.61 (One
Dollar and Sixty One Cents) per share to $.10 (Ten Cents) per share.


Dated:  4/22/99

                                    /s/ William R. Stoddard                 
                                    WILLIAM R. STODDARD


                                    CYCLO3PSS CORPORATION
                                    Under Authority of the Board of Directors

                                    By:      /s/ Steve Sarich, Jr.         
                                          Member of the Board and of
                                          The Executive Compensation
                                          Committee

                                      23






                              EMPLOYMENT CONTRACT

      AN  AGREEMENT  made on March 1, 1998,  between  DURAND  SMITH  residing in
Placitas,  NM,  herein  referred  to as "SMITH"  and  CYCLO3PSS  CORPORATION,  a
Delaware  Corporation,  with business  offices  located at 3646 West 2100 South,
Salt Lake City, Utah, herein referred to as "CYCLO3PSS".

      In  consideration  of the mutual  covenants  and  promises  of the parties
hereto, CYCLO3PSS and STODDARD agree as follows:

      SECTION ONE - EMPLOYMENT:CYCLO3PSS  employs SMITH to act as Vice President
- - Research &  Development  for  CYCLO3PSS  Corporation,  and SMITH  accepts such
employment  with  CYCLO3PSS,  subject  to  the  terms  and  conditions  of  this
agreement.

      SECTION TWO - TERM OF EMPLOYMENT: The effective term of this agreement and
the  employment  hereunder  shall commence on March 23, 1998, and continue until
March 22, 2001.

      SECTION THREE - DUTIES OF SMITH: SMITH will serve CYCLO3PSS to the best of
his ability  under the  direction of the board of  directors of  CYCLO3PSS.SMITH
shall devote such of his time and energy as is necessary to timely  complete the
services and duties contemplated under this agreement.

      SECTION FOUR - REGULAR COMPENSATION:  SMITH' S salary shall be at the rate
of One Hundred and Twenty  Thousand ($  120,000.00)  dollars per calendar  year,
payable semi-monthly, during the life of this agreement.

      SECTION FIVE - INCENTIVE STOCK OPTION:  In addition to the compensation as
described above, and as a further incentive for SMITH to continue his employment
throughout the period defined above,  CYCLO3PSS  agrees to, and hereby grants to
SMITH,  options for the  purchase of THREE  HUNDRED AND FIFTY  THOUSAND  SHA.RES
(350,000) of newly issued  restricted common stock in concert with the execution
of this  Contract.  The options are granted at the beginning of each  employment
year  and  and  are  exercisable  at the  end of  each  calender  year  and  are
conditioned  only  by  section  twelve  of  this  Contract.  These  options  are
exercisable at a rate of ONE HUNDRED AND FIFTY THOUSAND  SHARES  (l50,000) first
year, ONE HUNDRED  THOUSAND SHARES  (l00,000)  second year, ONE HUNDRED THOUSAND
SHARES (l00,000) third year. The options are non-transferable other than by will
or the law of descent  and  distribution,  and  expire  upon the FIVE YEAR (5yr)
anniversary of the date on which they become exercisable.

      SECTION SIX - PRICE AND  VALUATION  OF THE OPTIONED  SHARES:  The optioned
shares are deemed granted upon the execution of this  Employment  Contract.  The
options are granted at the current  fair  market  value of the  Companys  common
stock,  which has been  determined  by Board of  Directors  of the Company to be
$1.61 (One  Dollar and Sixty One Cents) per share.  Said  exercise  price is the
average  closing  bid for such said  stock  during  the last five days  prior to
today, February 17, 1998.

                                      24

<PAGE>



      SECTION  SEVEN - HEALTH  CARE  INSURANCE  BENEFITS:  It is the  intent  of
CYCLO3PSS to provide SMITH and his dependants with health insurance  coverage on
a plan  specific  to key  executive  personnel.  CYCLO3PSS  shall have  complete
discretion in choosing the type of health  insurance  plan provided SMITH and in
choosing the insurance carrier and extent of insurance  coverage,  provided that
such health insurance plan will include hospital,  maternity, major medical, and
dental coverage for SMITH and his dependants. In the event it is determined that
establishing  such an  executive  plan is  inconsistent  with  federal  or state
statutes.  CYCLO3PSS  will provide the same health  insurance  benefits to SMITH
that are provided to other employees.

      SECTION  EIGHT -  MOVING  EXPENSES:  In the  event  SMITH is  required  by
CYCLO3PSS to move his residence  outside of the State of New Mexico,SMITH  shall
receive  towards any moving  expenses the amount actually spent for moving vans,
storage  of goods in  transit,  any  sales  commission  on the sale of  SMITH' S
present residence, and all motel and hotel room expense.

      SECTION NINE - REIMBURSEMENT FOR EXPENSES:SMITH shall be
authorized to incur reasonable  expenses on behalf of CYCLO3PSS  including,  but
not limited to, expenses for entertainment, travel, management seminars, related
travel and related use of the telephone.  CYCLO3PSS  shall  reimburse  SMITH for
reasonable  out-of pocket  expenses which SMITH may incur in connection with his
services  for  CYCLO3PSS  contemplated  herein,  provided  that  SMITH  presents
appropriate vouchers evidencing any such expenses to CYCLO3PSS.

      SECTION TEN - SMITH'S SERVICE AS DIRECTOR: SMITH hereby consents to
serve,  if duly  elected,  as a  director  of  CYCLO3PSS  or any  subsidiary  or
corporation  affiliated with CYCLO3PSS.  However,SMITH' S employment  during the
employment  period as defined above is not  conditioned  by, nor contingent upon
SMITH'S participation as a member of the Board of Directors.

      SECTION ELEVEN - INDEMNIFICATION OF SMITH: CYCLO3PSS shall
indemnify  SMITH to the full  extent  permitted  by law  against  all  expenses,
attorney's fees, judgments,  fines and amounts paid in settlement,  actually and
reasonably  incurred  by SMITH in  connection  with any  threatened,  pending or
completed action, suit or proceeding, whether civil, criminal, administrative or
investigative, incurred by SMITH in connection with any act or omission by SMITH
occasioned  under this agreement,  provided that he acted in good faith and in a
manner he  reasonably  believed to be in or not opposed to the best  interest of
CYCLO3PSS and  provided,  with respect to any criminal  action,  that he did not
have reasonable cause to believe his conduct was unlawful.

      SECTION TWELVE -TERMINATION: This agreement may be terminated by CYCLO3PSS
for cause only. Cause shall be defined as fraud, misappropriation or intentional
material  damage  to  the  property  or  business  of  CYCLO3PSS,  or  by  board
determination  of  inadequate  performance.  SMITH may cancel this  agreement on
Sixty (60) days  written  notice for any reason.  If CYCLO3PSS  terminates  this
agreement  without cause,  CYCLO3PSS  shall pay to SMITH, an amount equal to the
remaining compensation set forth in Section Four and Five

                                      25

<PAGE>



hereof from the date of termination to the expiration date of this agreement. If
SMITH  terminates this agreement,  or if CYCLO3PSS  terminates this Contract for
cause,SMITH will receive only that compensation earned by him up to the point of
his  termination  including  stock  options and bonuses then due as set forth in
sections Four and Five, with the non-competition and non- disclosure  provisions
of Section Thirteen remaining in effect  notwithstanding the termination of this
agreement.

      SECTION THIRTEEN - NON-COMPETITION AFTER TERMINATION: SMITH
agrees that in addition to any other limitation, for a period of 24 months after
the  termination of his employment  hereunder,  and unless  otherwise  specified
herein,  he will not  directly  or  indirectly  engage  in, or in any  manner be
connected  with or employed by any person,  firm or  corporation  in competition
with  CYCLO3PSS  or any of its  subsidiaries,  or engaged in  providing  similar
products  and  services  as  CYCLO3PSS  or any of its  subsidiaries,  within the
territorial limits of the United States of America.

      SECTION FOURTEEN - USE OF CONFIDENTIAL INFORMATION: SMITH
recognizes  and  acknowledges  that he will have access to certain  confidential
information  of CYCLO3PSS or other  division or subsidiary of CYCLO3PSS and that
such information constitutes valuable,  special and unique property of CYCLO3PSS
and such other entities.  SMITH agrees that in addition to any other limitation,
regardless of the  circumstances  of the termination of employment,  he will not
communicate  to  any  person,   firm,  or  corporation  any  such   confidential
information relating to any product,  patent, patent pending, FDA Certification,
license,  certificate,  design, customer lists, prices, secrets, advertising, or
any  confidential  knowledge or secrets which he might from time to time acquire
with  respect to the business of  CYCLO3PSS  or any of its  subsidiaries,  for a
period of five years after termination or whenever information becomes available
to the public, whichever comes first.

      SECTION  FIFTEEN  -  COMMUNICATIONS  TO  CYCLO3PSS:  From  the  time  this
agreement commences until the termination  thereof,  SMITH shall communicate and
channel to CYCLO3PSS  all  knowledge,  business and customer  contracts  and any
other matters of information  which could concern or be in any way beneficial to
the business of CYCLO3PSS,  whether acquired by SMITH before or during the terms
of this agreement,  provided, however, that nothing hereunder shall be construed
as requiring such  communications  where the  information is lawfully  protected
from  disclosure  as a trade  secret  of a third  party.  Any  such  information
communicated  to  CYCLO3PSS  as  aforesaid  shall be and remain the  property of
CYCLO3PSS, notwithstanding the subsequent termination of this agreement.

      SECTION SIXTEEN - BINDING  EFFECT:  This agreement shall be binding on and
shall insure to the benefit of CYCLO3PSS, or any successor (s) of CYCLO3PSS, and
the personal  representatives of SMITH. CYCLO3PSS may assign all of its interest
in  this  agreement,  subject  to  all  the  obligations  of  CYCLO3PSS,  to any
third-party  interested  in  taking  over the  capital  stock  and  property  of
CYCLO3PSS,  and SMITH will fulfill for such  corporation any and all obligations
required under this agreement. In the event any such third-party taking over the
capital stock and/or property of CYCLO3PSS  terminates this employment agreement
for any reason other than cause as defined in Section  Twelve  hereof,  STODDARD
shall be entitled to his full compensation  hereunder  remaining under the THREE
(3) year terms of this employment

                                      26

<PAGE>



agreement, including all bene~ts and/or rights set forth in Sections Four, Five,
Seven, Eight and Nine hereof.

      SECTION SEVENTEEN - LAW TO GOVERN CONTRACT: This agreement shall
be governed by the law of the State of Utah.

      SECTION EIGHTEN - MISCELLANEOUS: In the event a provision of this
agreement shall be construed  invalid or  unenforceable  by a court of competent
jurisdiction,   this  agreement  shall  be  construed  as  if  such  invalid  or
unenforceable provisions were omitted.

     In Witness  Whereof,  the parties have executed this  agreement the day and
year first above written.



                              /s/ Durand M. Smith 
                                  DURAND SMITH



                              CYCLO3PSS CORPORATION
                              Under Authority of the Board of Directors;



                               By:    /s/ Steve Sarich, Jr.                     
                                      Member of the Board and of
                                      The Executive Compensation
                                      Committee



Attest:




______________________





                                      27

<PAGE>



                              AMENDMENT NO. 1 TO

                              EMPLOYMENT CONTRACT

      The  undersigned  agree that  Section  Six of the  Employment  Contract is
hereby amended to reduce the exercise price of the option shares from $1.61 (One
Dollar and Sixty One Cents) per share to $.10 (Ten Cents) per share.

Dated: 4/23/99

                                    /s/ Durand M. Smith
                                    DURAND SMITH



                                    CYCLO3PSS CORPORATION
                                    Under Authority of the Board of Directors


                                    By:   /s/ Steve Sarich, Jr.             
                                          Member of the Board and of
                                          The Executive Compensation
                                          Committee

                                      28




             STOCK OPTION AGREEMENT FOR THE YEAR BEGINNING 6/1/97
                 PURSUANT TO AN EMPLOYMENT AGREEMENT BETWEEN
               MONDIS NKOY AND CYCLO3PSS MEDICAL SYSTEMS, INC.



      THIS  AGREEMENT is  effective as of the 31st day of May,  1997 (the "Grant
Date"),  by and between  CYCLO3PSS  MEDICAL  SYSTEMS,  INC. (the  "Company") and
Mondis Nkoy (the "0ptionee");

                                 WITNESSETH:

      WHEREAS,  0ptionee is the  Corporate  Secretary  of the  Company,  and the
Company  and its  board of  directors  consider  it  desirrable  and in its best
interests that Optionee be given an inducement to remain in the Company's employ
and to acquire a proprietary  interest in the Company, and an added incentive to
advance the interests of the Company by possessing an option to purchase  shares
of the Company's common stock (the "Stock"), and

      WHEREAS,  the  compensation  committee  of the Board of  Directors  of the
Company  (the  "Committee"  and  the  Board  of  Directors  of the  Company  has
authorized  the grant to  Optionee  of a stock  option  authorizing  0ptionee to
purchase shares of common stock of the Company (the "Common Stock"); and

     WHEREAS,  the Company and 0ptionee wish to further  confirm and outline the
terms and conditions of the option;

       NOW,  THEREFORE,  in  consideration  of the  mutual  covenants  contained
herein, it is hereby agreed between the parties hereto as follows:

      1. Grand of Option.  Subject to the terms,  restrictions,  limitations and
conditions stated herein and in the prospectus and the registration statement to
be filed  registering  the shares  underlying  this option,  the Company  hereby
grants to the  0ptionee an option (the  "Option") to purchase all or any part of
15,000  post-split  shares (after the 1:5 reverse stock split approved on August
26, 1993 and  effective  September 8 1993) of common  stock of the Company  (the
"Shares" ).

     2.  Term  and  Exercise  of  Option.  Subject  to the  provisions  of  this
Agreement: 

     (a) This  option may be  exercised  by the  optionee at any time during the
0ption  Period,  as defined in Section 4 hereof which  provides that none of the
Options granted herein will be exercisable until May 31, 2000. At that date, all
of the options  granted  herein will then be  exersisable  unless the ootionee's
employment with the Company has terminated prior to May 31, 2000, in which event
the number of options  exercisable  will be reduced by 416 shares for each month
or part thereof between the date of termination and May 31, 2000.  However,  the
intervenin  death of 0ptionee  before May 31,  2000 will  remove this  continued
employment condition from all options granted herein.


                                      29

<PAGE>



            (b) Subject to Section 7 hereof,  the Option may be  exercised  with
      respect the exercisable portion thereof at any time after May 31, 2000 and
      prior  to the  expiration  date by the  delivery  to the  Company,  at its
      principal place of business, of:

      (i) a written notice of exercise in substantially the form attached hereto
      as Exhibit 1 , which shall be actually delivered to the Company no earlier
      than  thirty  (30) days and no later than ten ( 10) days prior to the date
      upon which Optionee desires to exercise all or a portion of 0ption;

      (ii)  payment to the Company of the Exercise  Price,  defined in Section 3
      below,multiplied  by the nurmber of shares being  purchased (the "Purchase
      Price") in the manner provided in Subsection (c) hereof; and

      (iii)  payment  of all  withholding  tax  obligations,  if  any,  (whether
      federal, state or local) imposed by reason of the exercise of the Option.

      Upon  receipt of such  notice,  receipt of payment in full of the Purchase
      Price,  and receipt of payment of any withholding tax obligations due, the
      Company shall cause to be issued an unrestricted  certificate representing
      the Shares purchased.

            (c) The Purchase  Price and  withholding  tax  obligations,  if any,
      shall be paid in full upon the  exercise of an Option and no Shares  shall
      be issued or delivered until full payment therefor has been made.  Payment
      of the Purchase Price for Shares purchased  pursuant to the exercise of an
      Option and any tax withholding obligations shall be made:

      (i) in cash or by certified check;or

      (ii) by delivery  to the Company of a number of shares of common  stock of
      the Company  which have been owned by the optionee for at least six months
      prior to the date of the  Option's  exercise  and which have a fair market
      value on the date of exercise, as determined by the Compensation Committee
      in its sole  discretion,  which is either equal to or which in combination
      with cash is equal to the purchase price; or

      (iii) by receipt of the  purchase  price in cash from a broker,  dealer or
      other  "creditor"  as  defined  by  Regulation  "T" issued by the Board of
      Governors of the Federal Reserve System following delivery by the optionee
      to the committee of instructions regarding delivery to such broker, dealer
      or other  "creditor"of  that number of shares of common stock with respect
      to which the Option is exercised.

      3. Exercise  Price.  The exercise price for each share of Common Stock for
which the 0ption is exercised  shall be 95 cents per share subject to adjustment
as set forth in Section 7 hereof (the "Exercise Price").  Said Exercise Price is
not less  than  l00% of the fair  market  value of such  stock as of the date of
action by the Compensation Committee.

      4. Term and Termination of 0ption.  Except as otherwise  provided  herein,
the term of the option (the "Option  Period")  shall  commence three years after
the Grant Date, provided that

                                      30

<PAGE>



the Optionee continues to serve as an employee of the Company for at least three
(3) years after the Grant Date, and shall terminate on the eighth anniversary of
the Grant  Date.  Upon  expiration  of the Option  Period this  Option,  and all
unexercised rights granted to Optionee hereunder, shall terminate and thereafter
be null and void.

      5. Rights as  Shareholders.  Until the stock  certificates  reflecting the
Shares  accruing to the Optionee  upon  exercise of the Option are issued to the
Optionee,  the Optionee  shall have no rights as a  shareholder  with respect to
such  Shares.   The  Company  shall  make  no  adjustment   for  any  dividends,
distributions or other rights on or with respect to Shares purchased pursuant to
the  Option  for which the record  date is prior to the  issuance  of that stock
certificate.

      6.  Restriction  on Transfer  of Option.  The Option  evidenced  hereby is
nontransferable other than by last will and testament or the laws of descent and
distribution, and, shall be exercisable during the lifetime of the Optionee only
by  the  Optionee  (or  in  the  event  of  his  disability,   by  his  personal
representative) and after his death, only by his personal representative.

      7.  Change in  Capitalization,  Change in  Control,  etc. If the number of
shares of the Common  Stock of the Company  shall be  increased  or reduced by a
stock  split  (other than the 1:5  reverse  stock split  approved on 8/26/93 and
effective 9/8/93 which has already been given effect herein), payment of a stock
dividend,  a subdivision or combination of shares,  reclassification,  merger or
consolidation, or similar capital adjustment, an appropriate adjustment shall be
made by the  Committee  in the number and kind of shares as to which the Option,
or the portion thereof then unexercised,  shall be or become exercisable, to the
end that the Optionee's proportionate interest shall be maintained as before the
change in the total price applicable to the unexercisable  portion of the Option
and with a corresponding  adjustment in the Exercise Price. All adjustments made
by the Committee under this Section shall be conclusive.

      If the  Company  shall  be the  surviving  corporation  in any  merger  or
consolidation,   recapitalization,   reclassification   of  shares  or   similar
reorganization,  an  appropriate  adjustment  shall be made with  respect to the
Shares so that the Optionee  shall be entitled to purchase at the same times and
upon the same terms and conditions as are then provided by this  Agreement,  the
number and class of securities to which a holder of the number of Shares subject
to the  Agreement  at the time of the  transaction  would have been  entitled to
receive as a result of such transaction,  with any corresponding adjustment made
to the Exercise Price.

      In the event of (a) a dissolution  or  liquidation  of the Company;  (b) a
merger of the Company  into another  corporation,  or any  consolidation,  share
exchange, combination,  reorganization, or like transaction in which the Company
is not the  survivor;  (c) a sale or transfer  (other  than as security  for the
Company's  obligations) of at least a majority if the assets of the Company;  or
(d) a sale or  transfer of 5O% or more of the issued and  outstanding  shares of
Common Stock by the holders  thereof in a single  transaction  or in a series of
related transactions,  the 0ption shall become immediately exercisable as to all
Shares  subject  thereto to the extent it has not already become so. The Company
shall use its best  efforts  to provide  Optionee  with  written  notice of such
transaction at least thirty (30) days prior to the date of its consummation


                                      31

<PAGE>



      8.  Legend  on Stock  Certificates.  Until  and  unless  the  registration
statement  to be filed  .which is intended  to register  the shares to be issued
pursuant  to  the  exercise  of  the  options   granted   herein  is  effective,
Certificates evidencing Common Stock to be distributed pursuant to the Agreement
and  the  Plan  shall,  to the  extent  appropriate  at  the  time,  have  noted
conspicuously  on the  certificates an appropriate  restrictive  legend which is
intended to give all persons  full notice of the  existence  of any  conditions,
restrictions,  rights and obligations related to the free transferability of the
shares issued.

      9. Governing  Laws. This Agreement  shall be construed,  administered  and
enforced  according  to the laws of the  State of Utah;  provided,  however,  no
option  may be  exercised  except  in the  reasonable  judgment  of the Board of
Directors,  in compliance with exemptions under applicable state securities laws
of the  state in  which  the  Optionee  resides,  and/or  any  other  applicable
securities laws.

      10.  Successors.  This  Agreement  shall be binding upon and insure to the
benefits of the heirs, legal  representatives,  successors and permitted assigns
of the parties.

      1l. Notice.  Except as otherwise  specified herein,  all notices and other
communications under this Agreement shall be in writing and shall deemed to have
been given if personally  delivered or if sent by registered or certified United
States  mail,  return  receipt  requested,  postage  prepaid,  addressed  to the
proposed  recipient at the last known  address of the  recipient.  Any party may
designate  any other  address to which notices shall be sent by giving notice of
the address to the other parties in the same manner as provided herein.

      12.  Severabitity.  In the event that any one or more of the provisions or
portion  thereof  contained in this Agreement shall for any reason be held to be
invalid,  illegal or unenforceable in any respect, the same shall not invalidate
or otherwise affect any other  provisions of this Agreement,  and this Agreement
shall be  construed  as if the invalid,  illegal or  unenforceable  provision or
portion thereof had never been contained herein.

     l3. Entire Agreement. Subject to the terms and conditions of the Plan, this
Agreement expresses the entire understanding and agreement of the parties.  This
Agreement  may be executed in two or more  counterparts,  each of which shall be
deemed  an  original  but  all of  which  shall  constitute  one  and  the  same
instruments.

      14. Violation. Any transfer, pledge, sale, assignment, or hypothecation of
the Option or any  portion  thereof  shall be a  violation  of the terms of this
Agreement and shall be void without effect.

     l5.  Headings.  Paragraph  headings  used  herein  are for  convenience  of
reference only and shall not be considered in construing this Agreement.

      16. Specific Performance. In the event of any actual or threatened default
in, or breach of, any of the terms, conditions and provisions of this Agreement,
the party or parties who are thereby  aggrieved shall have the right to specific
performance  and injunction in addition to any and all other rights and remedies
at law or in equity, and all such rights and remedies shall be cumulative.

      17. No Emplyment Rights Created. Neither the establishment of the Plan nor
the grant of the option  hereunder shall be construed as giving the Optionee the
right to continued employment with the Company or a subsidiary.

      IN WITNESS WHEREOF, the parties have executed and sealed this Agreement on
the day and year first set forth above.

                                      32

<PAGE>



                                    CYCLO3PSS MEDICAL SYSTEMS, INC.


                                     /s/ John M. Williams           
                                    By:  John M. Williams
                                    Title: CEO, President & Chairman

                                    OPTIONEE :



                                    /s/ Mondis Nkoy                     
                                    Mondis Nkoy



                                      33

<PAGE>



                              AMENDMENT NO. 1 TO

             STOCK OPTION AGREEMENT FOR THE YEAR BEGINNING 6/1/97
                  PURSUANT TO AN EMPLOYMENT AGREEMENT BETWEEN
                MONDIS NKOY AND CYCLO3PSS MEDICAL SYSTEMS, INC.

      The undersigned  agree that Section Three of the Stock Option Agreement is
hereby  amended to reduce the  exercise  price of the  option  shares  from $.95
(Ninety-Five Cents) per share to $.10 (Ten Cents) per share.


Dated:  4/23/99


                                    /s/ Mondis Nkoy                        
                                    MONDIS NKOY



                                    CYCLO3PSS CORPORATION
                                    Under Authority of the Board of Directors


                                    By: /s/ Steve Sarich, Jr.               
                                          Member of the Board and of
                                          The Executive Compensation
                                          Committee


                                      34






                                   AGREEMENT

      THIS AGREEMENT is entered into the 15th day of April, 1999 (the "Agreement
Date"),  by and  between  CYCLO3PSS  CORPORATION,  a Delaware  Corporation  (the
"Company"), and William R. Stoddard (the "Employee").

                                   RECITALS

      The Company owes Employee $18,000 for wages not paid.

      The Company  currently has limited cash flow and desires to pay such wages
by issuance of shares of Company stock.

      The Employee  agrees,  on the terms and  conditions  set forth herein,  to
accept 180,000 shares of CYCLO3PSS  common stock as payment for $18,000 of wages
not paid.

      1.  Issuance  of Stock.  The  Company  will  issue  180,000  shares of the
Company's common stock as payment in full of $18,000 of wages owed to William R.
Stoddard. The shares shall be issued at $.10 per share.

      2.  Acceptance  of Stock.  William  R.  Stoddard  accepts  180,000  of the
Company's common stock as payment in full of $18,000 of wages not paid.

      3.  Registration  of Shares.  The Shares have not been registered with the
Securities  and Exchange  Commission.  The Company shall use its best efforts to
register  the shares on Form S-8 and keep such  Registration  in effect with the
Securities  and Exchange  Commission as soon as practical and not later than six
months from the date hereof.

      4.    Miscellaneous.

      4.1 Amendments.  The terms and conditions of this Agreement may be amended
at any time by  mutual  agreement  of the  parties,  provided  that  before  any
amendment  shall be valid or effective it shall have been  approved by the Board
of Directors  of the  Company,  reduced to writing and signed by the Company and
the Employee.

      4.2 Governing  Law. This  Agreement  shall be governed by and construed in
accordance with the laws of the State of Utah.

      4.3 Entire  Agreement.  This Agreement  contains the entire  understanding
between  and among the  parties  and  supersedes  any prior  understandings  and
agreements among them respecting the subject matter of this Agreement.

      4.4 Further  Action.  The  parties  hereto  shall  execute and deliver all
documents,  provide all  information and take or forbear from all such action as
may be necessary or appropriate to achieve the purposes of the Agreement.

      4.5 Savings Clause. If any provision of this Agreement, or the application
of such  provision to any person or  circumstance,  shall be held  invalid,  the
remainder of this Agreement,  or the application of such provision to persons or
circumstances  other  than  those as to which it is held  invalid,  shall not be
affected thereby.

                                      35

<PAGE>



      4.6  Legal  Fees and  Expenses.  The  prevailing  party in any  proceeding
brought  to  enforce or  interpret  any  provision  of this  Agreement  shall be
entitled to recover its attorney's  fees,  costs and  disbursements  incurred in
connection  with such  proceeding,  including,  but not  limited to the costs of
experts, accountants and consultants and all other costs and services reasonably
related to the proceeding, including those incurred in any bankruptcy or appeal,
from the non-prevailing party or parties.


                                      36

<PAGE>



      IN WITNESS  WHEREOF,  the parties have executed this Agreement the day and
year first above-written.


CYCLO3PSS CORPORATION,                    Employee:
a Delaware Corporation:


By /s/ Mondis Nkoy                        By: /s/ William R. Stoddard
   -----------------------                    --------------------------
   Mondis Nkoy, Secretary                     William R. Stoddard










                                      37







                                                      Exhibit 5.1


                                  May 13, 1999


Cyclo3pss Corporation
3646 West 2100 South
Salt Lake City, Utah 84120

      Re:   Opinion Letter

Gentlemen:

      You have  requested  our opinion as counsel for Cyclo3pss  Corporation,  a
Delaware corporation (the "Company"),  in connection with the registration under
the  Securities  Act  of  1933,  as  amended,  and  the  Rules  and  Regulations
promulgated thereunder,  and the public offering by the Company of the following
described shares:  (1) up to 815,000 shares issuable at $.10 per share under the
terms of three  Employee  Stock  Option  Agreements;  (ii) up to 200,000  shares
issuable  at $1.07  per  share  under the  terms of two  Employee  Stock  Option
Agreements; and (iii) 180,000 shares issued as compensation in lieu of wages.

      You have  informed us that such shares were not and will not be issued for
capital  raising  services  and  under the terms of Form  S-8,  the  Company  is
entitled to register such shares on such Form.

      We have examined the Company's  Registration  Statement on Form S-8 in the
form to be filed with the  Securities  and Exchange  Commission  or about May 7,
1999 (the  "Registration  Statement").  We further have examined the Amended and
Restated  Certificate  of  Incorporation  of the  Company  as  certified  by the
Secretary of State of the State of Delaware,  the Bylaws and the minute books of
the Company as a basis for the opinion hereafter expressed.

      Based on the  foregoing  examination,  we are of the  opinion  that,  upon
issuance and sale in the manner  described in the  Registration  Statement,  the
shares of Common Stock  covered by the  Registration  Statement  will be legally
issued, fully paid and nonassessable.

      We consent to the filing of this opinion as an exhibit to the Registration
Statement.

                                    Sincerely,

                                    COHNE, RAPPAPORT & SEGAL, P.C.



                                    /s/ Cohne, Rappaport & Segal
                                    Cohne, Rappaport & Segal



                                      38





                                  EXHIBIT 23.1

                        Consent of Independent Auditors

      We consent to the incorporation by reference in the Registration Statement
(Form S-8 No. 33- XXX)  pertaining  to the  Employee  Stock  Option  Agreement -
William  R.  Stoddard,  Employee  Stock  Option  Agreement  - John M.  Williams,
Employment Agreement - William R. Stoddard, Employment Agreement - Durand Smith,
Employee Stock Option Agreements - Mondis Nkoy,  Agreement  (Regarding Shares in
Lieu of Cash  Salary) - William R.  Stoddard  in Lieu of Cash Wages of  Cyclopss
Corporation  of our report dated May 5, 1998,  with respect to the  consolidated
financial statements of Cyclopss Corporation included in its Annual Report (Form
10-KSB) for the year ended  February 28,  1998,  filed with the  Securities  and
Exchange Commission.


                                  /s/ Ernst & Young, LLP

Salt Lake City, UT
May 7, 1999




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission